Matches in Wikidata for { <http://www.wikidata.org/entity/Q90260439> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90260439 description "article scientifique publié en 2019" @default.
- Q90260439 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90260439 description "scientific article published on 24 September 2019" @default.
- Q90260439 description "wetenschappelijk artikel" @default.
- Q90260439 description "наукова стаття, опублікована 24 вересня 2019" @default.
- Q90260439 name "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 name "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 type Item @default.
- Q90260439 label "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 label "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 prefLabel "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 prefLabel "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 P1433 Q90260439-0779F5D1-D28A-447D-A461-14B70B396602 @default.
- Q90260439 P1476 Q90260439-6A9B1FA8-E126-4094-8146-64CD09B609C8 @default.
- Q90260439 P2093 Q90260439-7912F078-DBEA-44F2-AFC5-AB0111344A50 @default.
- Q90260439 P2093 Q90260439-80A0B5EF-E0A7-417D-9959-14F40ED40109 @default.
- Q90260439 P2093 Q90260439-884E2FA4-C582-4421-BD6A-1E8CA8647832 @default.
- Q90260439 P2093 Q90260439-A7B2C333-32B9-4D0B-818E-7F05E857D4B0 @default.
- Q90260439 P2093 Q90260439-B6A923CA-F824-4B2F-B0CB-B39D8848C0F7 @default.
- Q90260439 P2093 Q90260439-DF1DE540-E601-4333-9797-0E7E5D9A0EC7 @default.
- Q90260439 P2093 Q90260439-E82E472E-C7D5-43CF-970F-9EAA1211EC7A @default.
- Q90260439 P304 Q90260439-63398316-A948-4F6E-A9AD-E64B5E2F6FDE @default.
- Q90260439 P31 Q90260439-D8FD3813-9270-48F0-B1EE-00617F6E9450 @default.
- Q90260439 P356 Q90260439-62A8B14F-7919-4426-9D4E-1F90FD6E0723 @default.
- Q90260439 P433 Q90260439-04CC92C9-4D62-4E4A-BB2B-AA4FD0F216B1 @default.
- Q90260439 P478 Q90260439-0A7B920C-8F53-4A83-A63B-B2FD2F95D9D1 @default.
- Q90260439 P50 Q90260439-ADC11B97-EE47-43F4-987A-C03F5DB24B4B @default.
- Q90260439 P50 Q90260439-C29B0A7C-6DA3-43BA-8EC7-935E6982EA7D @default.
- Q90260439 P577 Q90260439-266D6324-D4B4-4554-A7E9-E20FBE52A480 @default.
- Q90260439 P698 Q90260439-74381AED-C458-4CFB-B5C6-551BF87BA9D1 @default.
- Q90260439 P356 WNL.0000000000008357 @default.
- Q90260439 P698 31551258 @default.
- Q90260439 P1433 Q1161692 @default.
- Q90260439 P1476 "The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms" @default.
- Q90260439 P2093 "Anja Ten Brinke" @default.
- Q90260439 P2093 "Annick de Vries" @default.
- Q90260439 P2093 "Birgit I Lissenberg-Witte" @default.
- Q90260439 P2093 "Djoeke Doesburg" @default.
- Q90260439 P2093 "Iris A Claessen" @default.
- Q90260439 P2093 "Iris Dekker" @default.
- Q90260439 P2093 "Theo Rispens" @default.
- Q90260439 P304 "e1579-e1586" @default.
- Q90260439 P31 Q13442814 @default.
- Q90260439 P356 "10.1212/WNL.0000000000008357" @default.
- Q90260439 P433 "17" @default.
- Q90260439 P478 "93" @default.
- Q90260439 P50 Q100533360 @default.
- Q90260439 P50 Q88518782 @default.
- Q90260439 P577 "2019-09-24T00:00:00Z" @default.
- Q90260439 P698 "31551258" @default.